Exclusive: India’s Supreme Court Reinstates Pfizer’s Sutent Patent; Orders Review For Patent Office
This article was originally published in PharmAsia News
Executive Summary
In a new twist, India’s Supreme Court restores Pfizer’s patent for Sutent, but also removes a restraining order that had prevented Cipla from launching a generic copy.